Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Moberg Pharma and Bayer Sign Exclusive License Agreement for MOB-015 in Europe
Wednesday, February 13, 2019Moberg Pharma has entered into a license agreement granting the Consumer Health division of Bayer exclusive European rights to MOB a new topical treatment of onychomycosis based on Mobergs patented proprietary formulation of terbinafine Bayer will be...
WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership
Tuesday, February 12, 2019WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing and Amicus Therapeutics Amicus Nasdaq FOLD a global patientdedicated biotechnology comp...
3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies
Tuesday, February 12, 2019SBio Inc and Verseau Therapeutics Inc announced today a partnership agreement focused on the development and commercialization of novel monoclonal antibodies in the field of immunooncology for a broad range of cancers Verseaus proprietary drug discov...
Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China
Monday, February 11, 2019Samsung Bioepis Co Ltd today announced its expansion in mainland China through a licensing agreement with CBridge Capital The agreement covers multiple biosimilar candidates from Samsung Bioepis including thirdwave biosimilar candidates SB and SB whi...
Cannabics Pharmaceuticals and Wize Pharma to Form Joint Venture to Develop Cannabinoid Based Ophthalmic Therapeutics
Friday, February 08, 2019Cannabics Pharmaceuticals Inc a world leader in personalized cannabinoid medicine focused on cancer and its side effects today announced that it has entered into agreement with Wize Pharma Inc OTCQB WIZP a clinicalstage biopharmaceutical company focu...
CStone and IMPACT Therapeutics' clinical collaboration progresses to IND filing acceptance for CS1001+IMP4297 combination therapy
Friday, February 08, 2019CStone Pharmaceutical and IMPACT Therapeutics Inc IMPACT today jointly announced that an Investigational New Drug IND filing has been accepted by the National Medical Products Administration NMPA for the combination of CStones fullyhuman antiPDL mono...
Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID® in Japan
Thursday, February 07, 2019Novelion Therapeutics Inc a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare metabolic diseases Novelion announced that its subsidiary Aegerion Pharmaceuticals Inc Aegerion has entered into an e...
Arrevus Finalizes Acquisition of Fusidic Acid (Taksta™) from Melinta Therapeutics
Thursday, February 07, 2019Arrevus Inc wwwarrevuscom a biotechnology company developing novel therapeutics for orphan diseases today announced that it has completed the acquisition of fusidic acid from Melinta Therapeutics Arrevus is now better positioned to advance its pipeli...
Taiho Pharmaceutical and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Tyrosine Kinase Inhibitor
Wednesday, February 06, 2019Taiho Pharmaceutical Co Ltd and Cullinan Oncology LLC announced on February an agreement to develop TAS a novel EGFR epidermal growth factor receptor tyrosine kinase inhibitor discovered by Taiho Pharmaceutical Under the terms of the agreement Ta...
Cellect Begins Collaboration with Washington University in Preparation for First U.S. Clinical Trial Using Cellect's ApoGraft™
Wednesday, February 06, 2019Cellect Biotechnology Ltd a developer of a novel stem cell production technology today announced a collaboration with Washington University a leading academic institution based in St Louis MO aimed at determining the safety and tolerability in a US P...
